| Syngene International Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 539268 |
NSE Symbol : SYNGENE |
P/E(TTM) : 51.66 |
|
ISIN Demat : INE398R01022 |
Div & Yield% : 0.33 |
EPS(TTM) : 7.43 |
|
Book Value(₹) : 116.55 |
Market Cap(₹Cr) : 15,492.82 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 663.00 | 960.00 | 834.40 | 830.10 | 799.30 | 948.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 663.00 | 960.00 | 834.40 | 830.10 | 799.30 | 948.40 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 24.80 | 21.60 | 14.50 | 14.20 | 16.60 | 18.40 |
| Total Income | 687.80 | 981.60 | 848.90 | 844.30 | 815.90 | 966.80 |
| Total Expenditure | 598.10 | 683.10 | 715.50 | 652.60 | 631.20 | 638.40 |
| PBIDT | 89.70 | 298.50 | 133.40 | 191.70 | 184.70 | 328.40 |
| Interest | 4.10 | 6.50 | 6.20 | 7.40 | 5.90 | 10.10 |
| PBDT | 85.60 | 292.00 | 127.20 | 184.30 | 178.80 | 318.30 |
| Depreciation | 95.60 | 95.30 | 97.10 | 100.10 | 94.60 | 89.60 |
| Tax | 0.00 | 33.70 | 5.60 | 13.00 | 15.80 | 41.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.90 | 14.80 | 8.00 | 5.00 | -5.60 | 13.00 |
| Reported Profit After Tax | -2.10 | 148.20 | 16.50 | 66.20 | 74.00 | 174.40 |
| Extra-ordinary Items | -13.50 | -5.58 | -52.20 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 11.40 | 153.78 | 68.70 | 66.20 | 74.00 | 174.40 |
| EPS (Unit Curr.) | -0.05 | 3.68 | 0.41 | 1.65 | 1.84 | 4.34 |
| EPS (Adj) (Unit Curr.) | -0.05 | 3.68 | 0.41 | 1.65 | 1.84 | 4.34 |
| Calculated EPS (Unit Curr.) | -0.05 | 3.68 | 0.41 | 1.64 | 1.84 | 4.33 |
| Calculated EPS (Adj) (Unit Curr.) | -0.05 | 3.68 | 0.41 | 1.64 | 1.84 | 4.33 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.21 | 14.71 | 1.64 | 6.57 | 7.35 | 17.33 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.21 | 14.71 | 1.64 | 6.57 | 7.35 | 17.33 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 403.70 | 402.90 | 402.90 | 402.90 | 402.90 | 402.50 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.53 | 31.09 | 15.99 | 23.09 | 23.11 | 34.63 |
| PBDTM(%) | 12.91 | 30.42 | 15.24 | 22.20 | 22.37 | 33.56 |
| PATM(%) | -0.32 | 15.44 | 1.98 | 7.97 | 9.26 | 18.39 |
